Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis
| dc.citation.epage | 591 | pt_BR |
| dc.citation.issue | 9 | pt_BR |
| dc.citation.spage | 588 | pt_BR |
| dc.citation.volume | 76 | pt_BR |
| dc.creator | Branco, Luciana Prats | |
| dc.creator | Adoni, Tarso | |
| dc.creator | Apostolos-Pereira, Samira Luisa | |
| dc.creator | Brooks, Joseph Bruno Bidin | |
| dc.creator | Correa, Eber Castro | |
| dc.creator | Damasceno, Carlos Augusto | |
| dc.creator | Eboni, Audred Cristina Biondo | |
| dc.creator | Fezer, Leticia | |
| dc.creator | Gama, Paulo Diniz da | |
| dc.creator | Goncalves, Marcus Vinicius Magno | |
| dc.creator | Gomes, Sidney | |
| dc.creator | Grzesiuk, Anderson Kuntz | |
| dc.creator | Mendes, Maria Fernanda | |
| dc.creator | Morales, Rogerio Rizo | |
| dc.creator | Muniz, Andre | |
| dc.creator | Parolin, Monica Fiuza Koncke | |
| dc.creator | Pimentel, Maria Lucia Vellutini | |
| dc.creator | Ribeiro, Marlise de Castro | |
| dc.creator | Santos, Gutemberg Augusto Cruz dos | |
| dc.creator | Sato, Henry Koiti | |
| dc.creator | Scherpenhuijzen, Simone Batista | |
| dc.creator | Scorcine, Claudio | |
| dc.creator | Siquineli, Fabio | |
| dc.creator | Sousa, Nise Alexandra de Carvalho | |
| dc.creator | Varela, Daniel Lima | |
| dc.creator | Winckler, Tereza Cristina Avila | |
| dc.creator | Fragoso, Yara Dadalti | |
| dc.date.accessioned | 2019-02-27T15:01:45Z | |
| dc.date.available | 2019-02-26 | |
| dc.date.available | 2019-02-27T15:01:45Z | |
| dc.date.issued | 2018-09 | |
| dc.description.abstract | Treatment options for multiple sclerosis (MS) have changed over the last few years, bringing about a new category of drugs with more efficient profiles. However, these drugs have come with a whole new profile of potential adverse events that neurologists have to learn well and quickly. One of the most feared complications of these MS treatments is progressive multifocal leukoencephalopathy caused by the reactivation of the John Cunningham virus (JCV). Objective: To identify the serologic profile of JCV in patients with MS. Methods: Data on serum antibodies for JCV were obtained using the enzyme-linked immunosorbent assay provided by the STRATIFY-JCV program. Results: A total of 1,501 blood tests were obtained from 1,102 patients with MS. There were 633 patients (57.1%) who were positive for antibodies for JCV and 469 patients who were negative (42.9%). Twenty-three patients became positive after initially having negative JCV antibody status. The rate of seroconversion was 18.5% over 22 months. Conclusion: The JCV serologic profile and seroconversion in Brazilian patients were similar to those described in other countries. | pt_BR |
| dc.description.resumo | As opçÔes terapĂȘuticas para esclerose mĂșltipla (EM) modificaram-se ao longo dos Ășltimos anos, trazendo uma nova categoria de drogas com melhor perfil de eficĂĄcia. No entanto, estas drogas vieram com um novo perfil de potenciais eventos adversos que exigem que o neurologista os reconheça bem e rapidamente. Uma das complicaçÔes mais temidas destes tratamentos para a EM Ă© a leucoencefalopatia multifocal progressiva (LEMP), causada pela reativação do vĂrus John Cunningham (JCV). Objetivo: Identificar o perfil sorolĂłgico de JCV em pacientes com EM. MĂ©todos: Dados sorolĂłgicos de JCV foram obtidos atravĂ©s do ensaio por enzimas imuno-adsorvidas (ELISA) fornecido pelo programa STRATIFY-JCV. Resultados: Um total de 1.501 testes sanguĂneos foram obtidos de 1.102 pacientes com EM. O grupo teve 633 pacientes (57,1%) soropositivos para anticorpos anti-JCV e 469 pacientes negativos (42,9%). Vinte e trĂȘs pacientes se tornaram posivitos apĂłs resultados iniciais negativos para anticorpos anti-JCV. A taxa de soroconversĂŁo foi 18,5% em 22 meses. ConclusĂŁo: O perfil sorolĂłgico do JCV e a soroconversĂŁo nos pacientes brasileiros foi semelhante Ă quela descrita em outros paĂses. | pt_BR |
| dc.identifier.doi | http://dx.doi.org/10.1590/0004-282x20180083 | pt_BR |
| dc.identifier.uri | https://repositorio.ufjf.br/handle/ufjf/9232 | |
| dc.language | eng | pt_BR |
| dc.publisher | - | pt_BR |
| dc.publisher.country | Brasil | pt_BR |
| dc.publisher.initials | - | pt_BR |
| dc.relation.ispartof | Arquivos de Neuro-Psiquiatria | pt_BR |
| dc.rights | Acesso Aberto | pt_BR |
| dc.subject | Esclerose mĂșltipla | pt_BR |
| dc.subject | Leucoencefalopatia multifocal progressiva | pt_BR |
| dc.subject | VĂrus JC | pt_BR |
| dc.subject | Natalizumab | pt_BR |
| dc.subject | Multiple sclerosis | pt_BR |
| dc.subject | Leukoencephalopathy | pt_BR |
| dc.subject | Progressive multifocal | pt_BR |
| dc.subject | JC virus | pt_BR |
| dc.subject | Natalizumab | pt_BR |
| dc.subject.cnpq | - | pt_BR |
| dc.title | Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis | pt_BR |
| dc.title.alternative | Perfil sorolĂłgico do vĂrus John Cunningham (JCV) em pacientes com esclerose mĂșltipla | pt_BR |
| dc.type | Artigo de PeriĂłdico | pt_BR |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis.pdf
- Size:
- 94.35 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.15 KB
- Format:
- Item-specific license agreed upon to submission
- Description:
